Checkpoint inhibitors in lung cancer are not immune from cost-effectiveness analysis

Ronan J. Kelly, Thomas J. Smith

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1814-1816
Number of pages3
JournalJournal of Thoracic Oncology
Volume11
Issue number11
DOIs
StatePublished - Nov 13 2016

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this